Literature DB >> 4288498

Tumor immunity after viral oncolysis.

W A Cassel, R E Garrett.   

Abstract

Mesh:

Year:  1966        PMID: 4288498      PMCID: PMC276326          DOI: 10.1128/jb.92.3.792-.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  2 in total

1.  IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS. I. MECHANISM OF IMMUNITY TO EHRLICH ASCITES TUMOR.

Authors:  J LINDENMANN
Journal:  J Immunol       Date:  1964-06       Impact factor: 5.422

2.  NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

Authors:  W A CASSEL; R E GARRETT
Journal:  Cancer       Date:  1965-07       Impact factor: 6.860

  2 in total
  8 in total

1.  Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation.

Authors:  Gayathri Vijayakumar; Dmitriy Zamarin
Journal:  Methods Mol Biol       Date:  2020

Review 2.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

Review 3.  Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition.

Authors:  Janaina Fernandes
Journal:  Biomark Cancer       Date:  2016-07-28

Review 4.  Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients.

Authors:  Volker Schirrmacher
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

Review 5.  Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!

Authors:  Volker Schirrmacher
Journal:  Biomedicines       Date:  2016-07-20

Review 6.  Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy.

Authors:  Volker Schirrmacher; Stefaan van Gool; Wilfried Stuecker
Journal:  Biomedicines       Date:  2019-08-30

Review 7.  Newcastle Disease Virus at the Forefront of Cancer Immunotherapy.

Authors:  Bharat Burman; Giulio Pesci; Dmitriy Zamarin
Journal:  Cancers (Basel)       Date:  2020-11-28       Impact factor: 6.639

8.  Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.

Authors:  J Lindenmann; P A Klein
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.